Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.670
-0.150 (-8.24%)
Feb 5, 2026, 4:00 PM EST - Market closed
Marker Therapeutics Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$10.17
Upside
+508.98%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +498.80% | Dec 8, 2025 |
| WBB Securities | WBB Securities | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +648.50% | Apr 1, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +379.04% | Mar 5, 2025 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $11 → $19 | Strong Buy | Maintains | $11 → $19 | +1,037.72% | Oct 21, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +558.68% | Apr 30, 2024 |
| Roth Capital | Roth Capital | Strong Buy → Hold Downgrades $30 → $10 | Strong Buy → Hold | Downgrades | $30 → $10 | +498.80% | Feb 17, 2022 |
| Piper Sandler | Piper Sandler | Buy Initiates $60 | Buy | Initiates | $60 | +3,492.81% | Mar 25, 2021 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $60 | Buy | Initiates | $60 | +3,492.81% | Mar 19, 2021 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $60 | Buy | Initiates | $60 | +3,492.81% | Mar 18, 2021 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $50 → $25 | Buy → Hold | Downgrades | $50 → $25 | +1,397.01% | May 12, 2020 |
| Piper Sandler | Piper Sandler | Buy Maintains $100 → $60 | Buy | Maintains | $100 → $60 | +3,492.81% | Nov 13, 2019 |
| Roth Capital | Roth Capital | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +5,888.02% | May 30, 2019 |